AKT1 and lung cancer: The combined use of glucose deprivation and AKT or autophagy inhibitors could improve the sensitivity of acquired erlotinib for nonsmall cell lung cancer.23 In the present study, increased glucose consumption and lactate secretion in the cetuximab‐resistant cells suggested that glucose metabolism might be involved in cetuximab resistance.